Industry Press Release

Latest Stories
The product offers proven performance against Mannheimia haemolytica, while adding protection against common viral causes of BRD, including BVD Types 1 and 2 and IBR.
Two students, from Michigan and Ohio, were selected.
FERA is relocating to a new 5,000-square-foot facility in Texas with expansive office, laboratory and warehouse space.
Elanco Animal Health announces Increxxaä (tulathromycin injection) for the treatment of bovine respiratory disease (BRD).
Dr. Baysinger was recognized for her significant contribution and achievements to the animal health industry, including mentoring and developing future women leaders.
Elanco’s new protein, planet and pet pledges aim to provide improved access to nutritious protein, reduce the company’s footprint on the planet, and support healthy pets that support people’s wellbeing.
The combination approvals allow Optigrid 45 to be used with other feed additives commonly fed to feedlot cattle, including monensin, tylosin and melengestrol.
Merck Animal Health has announced that Bovilis Nasalgen 3-PMH, the first intranasal vaccine, is now available to protect cattle from five of the most common pneumonia-causing viral and bacterial pathogens.
Primary scours disease-causing agents include bacteria such as E. coli and clostridium, and viruses such as rota and corona, and typically more than one pathogen is involved.
The company also is transitioning a key global manufacturing role from its global headquarters in Ingelheim, Germany, to the United States.